Production of SARS-CoV-2 pseudotyped viral particles for the evaluation of new therapies against COVID-19. FAVET [Internet]. 2022 May 24 [cited 2026 Apr. 28];20(Suppl.):44-50. Available from: https://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/FAVEveterinaria/article/view/11544